CenterBook Partners’s Tandem Diabetes Care TNDM Stock Holding History

CenterBook Partners’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-6,929	Closed	-$205K	–	486
2023 Q4	$205K	Buy	+6,929	New	+$144K	0.03%	376
2022 Q3	–	Sell	-5,443	Closed	-$322K	–	448
2022 Q2	$322K	Buy	+5,443	New	+$447K	0.07%	320

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

CenterBook Partners's TNDM Position: Q1 2024 in Review

CenterBook Partners sold out of Tandem Diabetes Care (TNDM) in Q1 2024, closing a stake of 6,929 shares — an estimated $205K sold.

CenterBook Partners first reported a position in TNDM in Q2 2022 and held it in 2 quarters. The position peaked at $322K in Q2 2022. 291 funds tracked by Wall St. Rank hold TNDM as of Q1 2024.

CenterBook Partners reported no remaining Tandem Diabetes Care position as of Q1 2024 after selling out during the quarter.
CenterBook Partners sold 6,929 Tandem Diabetes Care shares in Q1 2024, an estimated $205K.
CenterBook Partners first reported a position in Tandem Diabetes Care in Q2 2022 and held it in 2 quarters.
CenterBook Partners's Tandem Diabetes Care position peaked at $322K in Q2 2022.
291 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2024.

Based on CenterBook Partners's 13F filing for Q1 2024, filed 10 May 2024.